NFKB1 and ulcerative colitis: firstly found that emodin reduced the expression of TLR5 and MyD88, up-regulated IκB levels, as well as inhibited the nuclear translocation of NF-κB p65 to ameliorate ulcerative colitis symptoms, via suppressing flagellin-TLR5-NF-κB signaling pathway [25].